Atlas Trials

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Clinical trial NCT04200443 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04200443
Sponsor
City of Hope Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic LeiomyosarcomaMetastatic Soft Tissue SarcomaStage III Uterine Corpus Leiomyosarcoma AJCC v8Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8Stage IV Uterine Corpus Leiomyosarcoma AJCC v8Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8Unresectable LeiomyosarcomaUnresectable Soft Tissue Sarcoma
Start date
2020-01-14
Primary completion
2025-04-04
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.